Aurora kinasi (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Aurora kinasi" in Italian language version.

refsWebsite

Global rank Italian rank

13nih.gov

4^th place

9^th place

11doi.org

2^nd place

7^th place

6oadoi.org

799^th place

22^nd place

doi.org

dx.doi.org

Bolanos-Garcia VM, Aurora kinases, in Int. J. Biochem. Cell Biol., vol. 37, n. 8, 2005, pp. 1572-7, DOI:10.1016/j.biocel.2005.02.021, PMID 15896667.
Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN, Gandara DR, Aurora kinases as anticancer drug targets, in Clin. Cancer Res., vol. 14, n. 6, 2008, pp. 1639-48, DOI:10.1158/1078-0432.CCR-07-2179, PMID 18347165.
Pitts TM, Kulikowski GN, Tan AC, Murray BW, Arcaroli JJ, Tentler JJ, Spreafico A, Selby HM, Kachaeva MI, McPhillips KL, Britt BC, Bradshaw-Pierce EL, Messersmith WA, Varella-Garcia M, Eckhardt SG, Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer models, in Front Pharmacol, vol. 4, 2013, p. 35, DOI:10.3389/fphar.2013.00035, PMC 3610060, PMID 23543898.
Failes TW, Mitic G, Abdel-Halim H, Po'uha ST, Liu M, Hibbs DE, Kavallaris M, Evolution of resistance to Aurora kinase B inhibitors in leukaemia cells, in PLoS ONE, vol. 7, n. 2, 2012, pp. e30734, DOI:10.1371/journal.pone.0030734, PMC 3281142, PMID 22359551.
Fu J, Bian M, Jiang Q, Zhang C, Roles of Aurora kinases in mitosis and tumorigenesis, in Mol. Cancer Res., vol. 5, n. 1, 2007, pp. 1-10, DOI:10.1158/1541-7786.MCR-06-0208, PMID 17259342.
Lee EC, Frolov A, Li R, Ayala G, Greenberg NM, Targeting Aurora kinases for the treatment of prostate cancer, in Cancer Res., vol. 66, n. 10, 2006, pp. 4996-5002, DOI:10.1158/0008-5472.CAN-05-2796, PMID 16707419.
Gavriilidis P, Giakoustidis A, Giakoustidis D, Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review, in J Clin Med Res, vol. 7, n. 10, 2015, pp. 742-51, DOI:10.14740/jocmr2295w, PMC 4554212, PMID 26345296.
de Groot CO, Hsia JE, Anzola JV, Motamedi A, Yoon M, Wong YL, Jenkins D, Lee HJ, Martinez MB, Davis RL, Gahman TC, Desai A, Shiau AK, A Cell Biologist's Field Guide to Aurora Kinase Inhibitors, in Front Oncol, vol. 5, 2015, p. 285, DOI:10.3389/fonc.2015.00285, PMC 4685510, PMID 26732741.
Ke CS, Liu HS, Yen CH, Huang GC, Cheng HC, Huang CY, Su CL, Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs, in J. Nutr. Biochem., vol. 25, n. 5, 2014, pp. 526-39, DOI:10.1016/j.jnutbio.2014.01.003, PMID 24613085.
Blakemore LM, Boes C, Cordell R, Manson MM, Curcumin-induced mitotic arrest is characterized by spindle abnormalities, defects in chromosomal congression and DNA damage, in Carcinogenesis, vol. 34, n. 2, 2013, pp. 351-60, DOI:10.1093/carcin/bgs345, PMC 3564441, PMID 23125222.
Liu HS, Ke CS, Cheng HC, Huang CY, Su CL, Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of aurora A, in Mol. Pharmacol., vol. 80, n. 4, 2011, pp. 638-46, DOI:10.1124/mol.111.072512, PMID 21757545.

nih.gov

ncbi.nlm.nih.gov

Giet R, Prigent C, Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases, in J. Cell. Sci., 112 ( Pt 21), 1999, pp. 3591-601, PMID 10523496.
Bolanos-Garcia VM, Aurora kinases, in Int. J. Biochem. Cell Biol., vol. 37, n. 8, 2005, pp. 1572-7, DOI:10.1016/j.biocel.2005.02.021, PMID 15896667.
Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN, Gandara DR, Aurora kinases as anticancer drug targets, in Clin. Cancer Res., vol. 14, n. 6, 2008, pp. 1639-48, DOI:10.1158/1078-0432.CCR-07-2179, PMID 18347165.
Pitts TM, Kulikowski GN, Tan AC, Murray BW, Arcaroli JJ, Tentler JJ, Spreafico A, Selby HM, Kachaeva MI, McPhillips KL, Britt BC, Bradshaw-Pierce EL, Messersmith WA, Varella-Garcia M, Eckhardt SG, Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer models, in Front Pharmacol, vol. 4, 2013, p. 35, DOI:10.3389/fphar.2013.00035, PMC 3610060, PMID 23543898.
Failes TW, Mitic G, Abdel-Halim H, Po'uha ST, Liu M, Hibbs DE, Kavallaris M, Evolution of resistance to Aurora kinase B inhibitors in leukaemia cells, in PLoS ONE, vol. 7, n. 2, 2012, pp. e30734, DOI:10.1371/journal.pone.0030734, PMC 3281142, PMID 22359551.
Fu J, Bian M, Jiang Q, Zhang C, Roles of Aurora kinases in mitosis and tumorigenesis, in Mol. Cancer Res., vol. 5, n. 1, 2007, pp. 1-10, DOI:10.1158/1541-7786.MCR-06-0208, PMID 17259342.
Lee EC, Frolov A, Li R, Ayala G, Greenberg NM, Targeting Aurora kinases for the treatment of prostate cancer, in Cancer Res., vol. 66, n. 10, 2006, pp. 4996-5002, DOI:10.1158/0008-5472.CAN-05-2796, PMID 16707419.
Yang H, Ou CC, Feldman RI, Nicosia SV, Kruk PA, Cheng JQ, Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells, in Cancer Res., vol. 64, n. 2, 2004, pp. 463-7, PMID 14744757.
Gavriilidis P, Giakoustidis A, Giakoustidis D, Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review, in J Clin Med Res, vol. 7, n. 10, 2015, pp. 742-51, DOI:10.14740/jocmr2295w, PMC 4554212, PMID 26345296.
de Groot CO, Hsia JE, Anzola JV, Motamedi A, Yoon M, Wong YL, Jenkins D, Lee HJ, Martinez MB, Davis RL, Gahman TC, Desai A, Shiau AK, A Cell Biologist's Field Guide to Aurora Kinase Inhibitors, in Front Oncol, vol. 5, 2015, p. 285, DOI:10.3389/fonc.2015.00285, PMC 4685510, PMID 26732741.
Ke CS, Liu HS, Yen CH, Huang GC, Cheng HC, Huang CY, Su CL, Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs, in J. Nutr. Biochem., vol. 25, n. 5, 2014, pp. 526-39, DOI:10.1016/j.jnutbio.2014.01.003, PMID 24613085.
Blakemore LM, Boes C, Cordell R, Manson MM, Curcumin-induced mitotic arrest is characterized by spindle abnormalities, defects in chromosomal congression and DNA damage, in Carcinogenesis, vol. 34, n. 2, 2013, pp. 351-60, DOI:10.1093/carcin/bgs345, PMC 3564441, PMID 23125222.
Liu HS, Ke CS, Cheng HC, Huang CY, Su CL, Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of aurora A, in Mol. Pharmacol., vol. 80, n. 4, 2011, pp. 638-46, DOI:10.1124/mol.111.072512, PMID 21757545.

oadoi.org

Bolanos-Garcia VM, Aurora kinases, in Int. J. Biochem. Cell Biol., vol. 37, n. 8, 2005, pp. 1572-7, DOI:10.1016/j.biocel.2005.02.021, PMID 15896667.
Gautschi O, Heighway J, Mack PC, Purnell PR, Lara PN, Gandara DR, Aurora kinases as anticancer drug targets, in Clin. Cancer Res., vol. 14, n. 6, 2008, pp. 1639-48, DOI:10.1158/1078-0432.CCR-07-2179, PMID 18347165.
Fu J, Bian M, Jiang Q, Zhang C, Roles of Aurora kinases in mitosis and tumorigenesis, in Mol. Cancer Res., vol. 5, n. 1, 2007, pp. 1-10, DOI:10.1158/1541-7786.MCR-06-0208, PMID 17259342.
Lee EC, Frolov A, Li R, Ayala G, Greenberg NM, Targeting Aurora kinases for the treatment of prostate cancer, in Cancer Res., vol. 66, n. 10, 2006, pp. 4996-5002, DOI:10.1158/0008-5472.CAN-05-2796, PMID 16707419.
Ke CS, Liu HS, Yen CH, Huang GC, Cheng HC, Huang CY, Su CL, Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs, in J. Nutr. Biochem., vol. 25, n. 5, 2014, pp. 526-39, DOI:10.1016/j.jnutbio.2014.01.003, PMID 24613085.
Liu HS, Ke CS, Cheng HC, Huang CY, Su CL, Curcumin-induced mitotic spindle defect and cell cycle arrest in human bladder cancer cells occurs partly through inhibition of aurora A, in Mol. Pharmacol., vol. 80, n. 4, 2011, pp. 638-46, DOI:10.1124/mol.111.072512, PMID 21757545.